Tandem Diabetes Care (TNDM) Change in Account Payables (2013 - 2026)

Tandem Diabetes Care has reported Change in Account Payables for 12 years, with the latest figure at $13.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables rose 107.23% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2026 stood at $9.3 million (up 22.72% YoY), and the FY2025 full-year result was $2.2 million, up 193.1% from the prior year.
• Change in Account Payables for Q1 2026 stood at $13.8 million, up from $5.8 million in the prior quarter.
• The five-year high for Change in Account Payables was $13.8 million in Q1 2026, with the low at -$9.3 million in Q3 2025.
• Historically, Change in Account Payables has averaged $1.5 million across 3 years, with a median of -$898000.0 in 2025.
• The largest YoY upside for Change in Account Payables was 504.03% in 2025 against a maximum downside of 682.06% in 2025.
• Tandem Diabetes Care's Change in Account Payables stood at -$1.4 million in 2024, then jumped by 504.03% to $5.8 million in 2025, then soared by 136.4% to $13.8 million in 2026.
• The last three Change in Account Payables figures came in at $13.8 million (Q1 2026), $5.8 million (Q4 2025), and -$9.3 million (Q3 2025), per Business Quant data.